查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1638824

注射器市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Syringes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球注射器市场估值为196 亿美元，预计2024 年至2032 年复合年增长率为10.9%。的针头或喷嘴组成控制。

该市场的成长是由人口老化和慢性健康状况的增加所推动的，这增加了对安全、可靠的注射设备的需求。此外，随着患者在临床环境之外寻求更方便、更实惠的治疗解决方案，家庭医疗保健采用的增加支持注射器的使用。

市场按製剂分为即用型 (RTU) 和即用型 (RTS) 注射器。 RTU 领域引领市场，预计复合年增长率为 11.1%，因为它为医疗保健提供者和患者提供了便利。 RTU 注射器通常预先填充药物，可简化给药、最大限度地减少剂量错误并降低污染风险。它们的设计提高了依从性，特别是在慢性病管理方面，并且由于易于自我管理而越来越受到家庭医疗保健的青睐。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 196 亿美元
预测值 491 亿美元
复合年增长率 10.9%

按应用划分，市场分为小分子、诊断和生物製剂，到2023年，生物製剂将占据54.7%的份额。需求，这些药物需要精确的递送方法。向个人化医疗的转变进一步强调了对高效输送系统的需求，从而巩固了生物製剂的市场主导地位。

在北美，受先进的医疗基础设施、强大的研发力度和对医疗设备的高需求的推动，美国以 10.6% 的复合年增长率领先。美国对创新的重视催生了先进的注射器技术，包括安全设计和预填充选项，可提高病患安全和治疗效果。慢性病的增加和疫苗接种措施进一步刺激了市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病和老年人口增加
      • 加强疫苗接种力度
      • 关注病人安全的技术进步不断进步
      • 生物製剂和生物相似药研究活动的增加
    • 产业陷阱与挑战
      • 针刺伤的风险很高
      • 严格的监管要求
  • 成长潜力分析
  • 监管环境
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按准备情况，2021 - 2032 年

  • 主要趋势
  • 即用型 (RTU)
  • 准备灭菌 (RTS)

第 6 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 小分子
  • 生物製剂
  • 诊断

第 7 章：市场估计与预测：按材料划分，2021 - 2032 年

  • 主要趋势
  • 玻璃
  • 塑胶/聚合物

第 8 章：市场估计与预测：按规模，2021 - 2032

  • 主要趋势
  • <1毫升
  • 1毫升 - 2毫升
  • 3毫升 - 5毫升
  • 6 毫升 - 10 毫升
  • 10 - 20 毫升
  • 20 - 30 毫升
  • >30 毫升

第 9 章：市场估计与预测：依最终用途，2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 製药和生物技术公司
  • 合约开发与製造组织 (CDMO)
  • 诊断实验室
  • 其他最终用户

第 10 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：公司简介

  • Becton, Dickinson and Company (BD)
  • Cardinal Health
  • Corning
  • Daikyo Seiko
  • DWK Life Sciences
  • Gerresheimer AG
  • ICU Medical
  • Mitsubishi Gas Chemical Company
  • Nipro
  • SCHOTT Pharma (SCHOTT Group)
  • Shandong Province Medicinal Glass
  • SHIOTANI GLASS
  • Terumo
  • Weigao Group
  • West Pharmaceutical Services
简介目录
Product Code: 12084

The Global Syringes Market was valued at USD 19.6 billion in 2023, with projections indicating a 10.9% CAGR from 2024 to 2032. Syringes, vital medical devices for fluid injection and withdrawal, consist of a barrel, plunger, and needle or nozzle for precise fluid control.

Growth in this market is driven by an aging population and an increase in chronic health conditions, which elevate the demand for safe, reliable injection devices. Additionally, the rise in home healthcare adoption supports syringe use as patients seek more convenient and affordable treatment solutions beyond clinical settings.

The market is segmented by preparation into ready-to-use (RTU) and ready-to-sterilize (RTS) syringes. The RTU segment leads the market, with an anticipated 11.1% CAGR, owing to its convenience for healthcare providers and patients. Often prefilled with medication, RTU syringes simplify administration, minimize dosage errors, and reduce contamination risk. Their design promotes compliance, particularly in chronic disease management, and is increasingly favored in home healthcare due to the ease of self-administration.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$19.6 Billion
Forecast Value$49.1 Billion
CAGR10.9%

By application, the market is categorized into small molecules, diagnostics, and biologics, with biologics holding a 54.7% share in 2023. This segment's strength stems from the growing demand for biologic drugs targeting chronic and autoimmune conditions, which require precise delivery methods. The shift toward personalized medicine further underscores the need for efficient delivery systems, solidifying biologics' market dominance.

In North America, the U.S. leads with a CAGR of 10.6%, driven by advanced healthcare infrastructure, strong R&D efforts, and high demand for medical devices. The U.S. focus on innovation has produced advanced syringe technologies, including safety-engineered and prefilled options that enhance patient safety and treatment effectiveness. Rising chronic diseases and vaccination initiatives further stimulate market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising chronic diseases and geriatric population
      • 3.2.1.2 Increasing vaccination initiatives
      • 3.2.1.3 Growing technology advancement focusing on patient safety
      • 3.2.1.4 Rise in biologics and biosimilars research activities
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High risk of needlestick injuries
      • 3.2.2.2 Stringent regulatory requirements
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Future market trends
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Preparation, 2021 - 2032 ($ Mn and Units)

  • 5.1 Key trends
  • 5.2 Ready to use (RTU)
  • 5.3 Ready to sterilize (RTS)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Units)

  • 6.1 Key trends
  • 6.2 Small molecules
  • 6.3 Biologics
  • 6.4 Diagnostics

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn and Units)

  • 7.1 Key trends
  • 7.2 Glass
  • 7.3 Plastic/ polymers

Chapter 8 Market Estimates and Forecast, By Size, 2021 - 2032 ($ Mn and Units)

  • 8.1 Key trends
  • 8.2 <1 ml
  • 8.3 1 ml - 2 ml
  • 8.4 3 ml - 5 ml
  • 8.5 6 ml - 10 ml
  • 8.6 10 - 20 ml
  • 8.7 20 - 30 ml
  • 8.8 >30 ml

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

  • 9.1 Key trends
  • 9.2 Hospitals & clinics
  • 9.3 Pharma & biotech companies
  • 9.4 Contract development and manufacturing organizations (CDMOs)
  • 9.5 Diagnostic laboratories
  • 9.6 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Italy
    • 10.3.5 Spain
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 Becton, Dickinson and Company (BD)
  • 11.2 Cardinal Health
  • 11.3 Corning
  • 11.4 Daikyo Seiko
  • 11.5 DWK Life Sciences
  • 11.6 Gerresheimer AG
  • 11.7 ICU Medical
  • 11.8 Mitsubishi Gas Chemical Company
  • 11.9 Nipro
  • 11.10 SCHOTT Pharma (SCHOTT Group)
  • 11.11 Shandong Province Medicinal Glass
  • 11.12 SHIOTANI GLASS
  • 11.13 Terumo
  • 11.14 Weigao Group
  • 11.15 West Pharmaceutical Services